(2020). SARS‐CoV‐2 S1 and N‐based serological assays reveal rapid seroconversion and induction of specifc antibody response in COVID‐19 patients.
Chicago Style (17th ed.) CitationSARS‐CoV‐2 S1 and N‐based Serological Assays Reveal Rapid Seroconversion and Induction of Specifc Antibody Response in COVID‐19 Patients. 2020.
MLA (8th ed.) CitationSARS‐CoV‐2 S1 and N‐based Serological Assays Reveal Rapid Seroconversion and Induction of Specifc Antibody Response in COVID‐19 Patients. 2020.
Warning: These citations may not always be 100% accurate.